Fundz

Nls Pharmaceutics Ltd reported raising $1 Million in an initial SEC Form D filing, from an offering of $1 Million

PUBLIC · NCELJul 10, 2025

Amount Raised

$1 Million

$1 Million sold, per SEC Form D (first sale Jun 27, 2025)

Round Type

Seed

ZurichManufacturingBiotechnologyHealthcareHealth CareTherapeutics

Who to call at NLS Pharmaceutics Ltd, and when

A new round usually means NLS Pharmaceutics Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NLS Pharmaceutics Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NLS Pharmaceutics Ltd, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NLS Pharmaceutics Ltd

Location

THE CIRCLE 6

Zurich, Zurich, Switzerland

About

NLS Pharmaceutics is a biopharmaceutical company that specializes in developing innovative therapies for patients with central nervous system disorders. The company's focus includes a diversified pipeline aimed at addressing serious unmet medical needs. It aims to improve the lives of patients through advanced drug delivery systems and small-molecule expertise.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NLS Pharmaceutics Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsRonen T., Executive Chairman & CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for NLS Pharmaceutics Ltd's next move

See what Strategic adds

NLS Pharmaceutics Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.